Bhandari Krishnagopal, Kapoor Dharmesh
Yashoda Hospitals, Secunderabad, India.
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):617-624. doi: 10.1016/j.jceh.2021.08.028. Epub 2021 Sep 4.
Fatigue is a common symptom in patients with liver disease and has a significant impact on the health-related quality of life (HR-QoL). Its pathogenesis is poorly understood and is considered multifactorial. The liver is central in the pathogenesis of fatigue because it uniquely regulates much of the production, storage, and release of substrate for energy generation. Also, the liver "cross-talks" with the key organs that are responsible for this symptom complex-gut, skeletal muscle, and brain. Fatigue can have both peripheral (i.e., neuromuscular) and central (i.e., resulting from changes in neurotransmission within the brain) components. The treatment strategies for the management of fatigue are behavioral changes and pharmacotherapy, along with dietetic intervention and exercise. However, there is no consensus on management strategies for fatigue in patients with liver disease. This article gives an overview of fatigue as a concept, its pathophysiology, measures to evaluate fatigue in patients with liver disease, the impact of fatigue on chronic liver disease, assessment of fatigue in an appropriate clinical setting, and various interventions to manage fatigue.
疲劳是肝病患者的常见症状,对健康相关生活质量(HR-QoL)有重大影响。其发病机制尚不清楚,被认为是多因素的。肝脏在疲劳的发病机制中起核心作用,因为它独特地调节着许多能量产生底物的产生、储存和释放。此外,肝脏与导致这种症状复合体的关键器官——肠道、骨骼肌和大脑“相互作用”。疲劳可同时具有外周(即神经肌肉)和中枢(即由大脑内神经传递变化引起)成分。管理疲劳的治疗策略包括行为改变、药物治疗、饮食干预和运动。然而,对于肝病患者疲劳的管理策略尚无共识。本文概述了疲劳这一概念、其病理生理学、评估肝病患者疲劳的措施、疲劳对慢性肝病的影响、在适当临床环境中对疲劳的评估以及管理疲劳的各种干预措施。